@agenusbio.com
Our mission is to the power of the immune system to bring affordable, curative therapies to cancer patients
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
PNG
About
Description
Agenus Inc. With a focus on better immunotherapies, Agenus is committed to revolutionizing cancer immunotherapy. One of their groundbreaking advancements is botensilimab, a next-generation CTLA-4 antibody.
Botensilimab is designed to extend the curative benefits of immunotherapy to cold tumors that do not respond to approved treatments. It also aims to expand clinical benefit in hot tumors, such as melanoma, where current treatments have limited success. Agenus prioritizes innovation in immunotherapy to empower the immune system and cure diseases.
They have discovered that modifying the Fc tail of the antibody significantly enhances the efficacy and tolerability of botensilimab. At Agenus, their dedicated team, extensive pipeline, state-of-the-art manufacturing capabilities, and commitment to clinical publications and presentations demonstrate their dedication to improving cancer treatment. Join Agenus in their mission to revolutionize cancer immunotherapy and bring hope and healing to cancer patients worldwide
Company Type
Public Company
Company Size
201-500
Year Founded
1994
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories